<p>Obesity is a major factor in development of insulin resistance (IR) and metabolic features in polycystic ovary syndrome (PCOS) patients. Nearly two-thirds patients with PCOS (30 of 37 confirmed cases of PCOS) in our previous community based study were lean, in contrast to Caucasians. Metabolic parameters including IR and β cell function have not been characterized well in this group of lean PCOS. To study the metabolic features including IR and β cell function in lean PCOS patients, 53 patients with BMI, <23 kg/m<sup>2</sup> were compared with 71 obese PCOS and 45 age and body mass index matched controls. Lean patients had similar β cell function and IR as compared to controls and obese patients, though the latter group had more metaboli...
Evidence favours insulin resistance and compensatory hyperinsulinemia as the predominant, perhaps pr...
Although current evidence suggests increased risk of obesity, insulin resistance, and metabolic alte...
Polycystic ovary syndrome is a complex endocrinopathy with heterogeneous presentation and multifacto...
OBJECTIVE — To evaluate insulin sensitivity (IS) and -cell function (F) in lean and obese women with...
Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting 5-10% of pr...
This study was performed to assess insulin resistance (IR) in lean women with polycystic ovary syndr...
A bi‑directional relationship exists between obesity and polycystic ovary syndrome (PCOS). Although ...
AbstractPolycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by hyperandrogeni...
Polycystic ovary syndrome (PCOS) is associated with insulin resistance (IR) and compensatory hyperin...
ABSTRACT: Metabolic syndrome (MBS) is a common disorder related to visceral obesity and insulin res...
Polycystic ovary syndrome (PCOS) is a common condition that typically develops in reproductive-age w...
Polycystic ovary syndrome (PCOS) is a common condition that typically develops in reproductive-age w...
Abstract OBJECTIVE: Muscle mass plays an important role in determining cardiovascular and metabolic ...
Objective: Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with metabolic...
Polycystic ovary syndrome (PCOS) is a common condition that typically develops in reproductive-age w...
Evidence favours insulin resistance and compensatory hyperinsulinemia as the predominant, perhaps pr...
Although current evidence suggests increased risk of obesity, insulin resistance, and metabolic alte...
Polycystic ovary syndrome is a complex endocrinopathy with heterogeneous presentation and multifacto...
OBJECTIVE — To evaluate insulin sensitivity (IS) and -cell function (F) in lean and obese women with...
Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting 5-10% of pr...
This study was performed to assess insulin resistance (IR) in lean women with polycystic ovary syndr...
A bi‑directional relationship exists between obesity and polycystic ovary syndrome (PCOS). Although ...
AbstractPolycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by hyperandrogeni...
Polycystic ovary syndrome (PCOS) is associated with insulin resistance (IR) and compensatory hyperin...
ABSTRACT: Metabolic syndrome (MBS) is a common disorder related to visceral obesity and insulin res...
Polycystic ovary syndrome (PCOS) is a common condition that typically develops in reproductive-age w...
Polycystic ovary syndrome (PCOS) is a common condition that typically develops in reproductive-age w...
Abstract OBJECTIVE: Muscle mass plays an important role in determining cardiovascular and metabolic ...
Objective: Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with metabolic...
Polycystic ovary syndrome (PCOS) is a common condition that typically develops in reproductive-age w...
Evidence favours insulin resistance and compensatory hyperinsulinemia as the predominant, perhaps pr...
Although current evidence suggests increased risk of obesity, insulin resistance, and metabolic alte...
Polycystic ovary syndrome is a complex endocrinopathy with heterogeneous presentation and multifacto...